MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0015098
Crenza Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.97 Cr
▲ 3% YoY
Net profit · FY 2025
₹25.81 Lakh
Net margin 4.3%
EBITDA · FY 2025
₹1.14 Cr
EBITDA margin 19.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
31
Provident fund records
About Crenza Pharmaceuticals Private Limited
Data last updated:
Crenza Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 22 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC117228. Its GSTIN is 36AAHCC0113G1Z8 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹50,000. It is led by directors Sandhya Pittala (Whole-Time Director) and Satyanarayana Pittala.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flot No.A – 27P Apie Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.97 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹25.81 Lakh (net margin 4.3%) and EBITDA of ₹1.14 Cr (EBITDA margin 19.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 13% over five years.
The company has about 31 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Crenza Pharmaceuticals. As per MCA filings, the company has open charges of ₹5 Cr on record.
Crenza Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0015098). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website crenzapharma.com.
Company details
CIN U24304TG2017PTC117228
Registration Number 117228
Incorporation Date 22 May 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0015098
Recognitions & Rankings of Crenza Pharmaceuticals
Contact details
Crenza Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is crenzapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlot No.A – 27P Apie Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Pharma Contract R&D, Drug Formulation & Development
To see the full contact details of Crenza Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Crenza Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Crenza Pharmaceuticals operates one associated brand: Crenza Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract-based development and manufacturing of pharmaceutical injectables and ophthalmic drugs. | crenzapharma.com |
Business activity
The main business activity of Crenza Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Crenza Pharmaceuticals Private Limited, buy the company report.
Financials of Crenza Pharmaceuticals Private Limited
FY 2025 filings availableCrenza Pharmaceuticals Private Limited reported revenue of ₹5.97 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹5.97 Cr ▲ 3%
Net profit · FY 2025
₹25.81 Lakh margin 4.3%
EBITDA · FY 2025
₹1.14 Cr margin 19.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 12%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▼ 1%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 3% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.1% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crenza Pharmaceuticals Private Limited, buy the company report.
Board of directors of Crenza Pharmaceuticals Private Limited
Crenza Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Pittala | Whole-Time Director | 22 May 2017 | 9 Years 5 Months | Current |
| Satyanarayana Pittala | Director | 30 May 2019 | 7 Years 5 Months | Current |
Auditor
Crenza Pharmaceuticals Private Limited is audited by RAMESHV for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMESHV | FY 2023 | 204088 |
Shareholding
The shareholding of Crenza Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Crenza Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2023 | 100726780 | Hdfc Bank Limited | ₹5 Cr | Open |
To see the full charge records of Crenza Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Crenza Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crenza Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Crenza Pharmaceuticals Private Limited has a workforce of 31 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
31
Active EPFO establishments
1
Employee growth
19.23%
GST
Crenza Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCC0113G1Z8 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Crenza Pharmaceuticals Private Limited, buy the company report.
Recent activity
Crenza Pharmaceuticals Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Pittala Soumya ceased to be Whole-Time Director on 04 Jun 2019.
AGM
Crenza Pharmaceuticals Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 500.00 Lakh registered on 06 May 2023 with Charge ID 100726780 was modified on 17 Jun 2025.
Filing
Crenza Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 500.00 Lakh with Charge ID 100726780 was registered on 06 May 2023.
Ceased
Pittala Soumya ceased to be Whole-Time Director.
Appointed
Satyanarayana Pittala was appointed as Director.
Appointed
Pittala Soumya was appointed as Whole-Time Director.
Appointed
Sandhya Pittala was appointed as Whole-Time Director.
Incorporation
22 May 2017
Crenza Pharmaceuticals Private Limited was registered on 22 May 2017 with Roc Hyderabad & aged 9 years 5 months as per MCA records.
Frequently asked questions
Crenza Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 22 May 2017 (9+ years old) and is registered under CIN U24304TG2017PTC117228.
Crenza Pharmaceuticals has 2 current directors:
- Sandhya Pittala - Whole-Time Director
- Satyanarayana Pittala - Director
The latest financial statements of Crenza Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Crenza Pharmaceuticals is 36AAHCC0113G1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Crenza Pharmaceuticals is U24304TG2017PTC117228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crenza Pharmaceuticals was incorporated on 22 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pittala Soumya ceased to be Whole-Time Director on 04 Jun 2019. Satyanarayana Pittala was appointed as Director on 30 May 2019. Pittala Soumya was appointed as Whole-Time Director on 22 May 2017. Crenza Pharmaceuticals has 4 board changes on record in total.
Yes, Crenza Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0015098).
Crenza Pharmaceuticals can be reached through the website crenzapharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Crenza Pharmaceuticals is at Flot No.A – 27P Apie Balanagar, Hyderabad, Telangana, India – 500037.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages